Enterosediv en es it fr

Enterosediv Brand names, Enterosediv Analogs

Enterosediv Brand Names Mixture

  • No information avaliable

Enterosediv Chemical_Formula


Enterosediv RX_link


Enterosediv fda sheet

Enterosediv FDA

Enterosediv msds (material safety sheet)

Enterosediv Synthesis Reference

No information avaliable

Enterosediv Molecular Weight

387.711 g/mol

Enterosediv Melting Point

No information avaliable

Enterosediv H2O Solubility

No information avaliable

Enterosediv State


Enterosediv LogP


Enterosediv Dosage Forms

Cream; Ointment; Suppository (each applicator-full provides approximately 4.6 grams of ointment containing 300 mg of tioconazole)

Enterosediv Indication

For the local treatment of vulvovaginal candidiasis (moniliasis).

Enterosediv Pharmacology

Tioconazole is a broad-spectrum imidazole antifungal agent that inhibits the growth of human pathogenic yeasts. Tioconazole exhibits fungicidal activity in vitro against Candida albicans, other species of the genus Candida, and against Torulopsis glabrata. Tioconazole prevents the growth and function of some fungal organisms by interfering with the production of substances needed to preserve the cell membrane. This drug is effective only for infections caused by fungal organisms. It will not work for bacterial or viral infections.

Enterosediv Absorption

Systemic absorption following a single intravaginal application of tioconazole in nonpregnant patients is negligible.

Enterosediv side effects and Toxicity

Symptoms of overdose include erythema, stinging, blistering, peeling, edema, pruritus, urticaria, burning,

Enterosediv Patient Information

Enterosediv Organisms Affected

Yeast and other fungi